Clinical trial

Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test

NCT05603299

Study summary

ClinicalTrials.gov

Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Educational Materials on the Dawn test Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2023-06-21

PhaseNA

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

Educational Materials on the Dawn testOTHER

Sponsors & collaborators

Qure Healthcare, LLClead sponsor

Venn Biosciences Corporationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05603299 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.